Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Jonuleit

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Allergy and Clinical Immunology|January 13, 2012
Allergen-induced IgE-dependent gut inflammation in a human PBMC-engrafted murine model of allergyBenno Weigmann, Nadja Schughart, Christian Wiebe, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2012
Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3+ regulatory T cellsMartin Vaeth, Ulrike Schliesser, Gerd Müller, et al.
The Journal of Biological Chemistry|June 7, 2006
Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responsesTobias Warger, Nobert Hilf, Gerd Rechtsteiner, et al.
Blood|May 15, 2009
Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cellsChristian Becker, Christian Taube, Tobias Bopp, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|May 4, 2013
Subclinical CNS inflammation as response to a myelin antigen in humanized miceMorad Zayoud, Khalifa El Malki, Katrin Frauenknecht, et al.
Blood|May 16, 2007
Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive functionJan Kubach, Petra Lutter, Tobias Bopp, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 4, 2015
FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosisFelix Luessi, Stefan Kraus, Bettina Trinschek, et al.
Plos One|September 25, 2009
miR-155 inhibition sensitizes CD4+ Th cells for TREG mediated suppressionHeiko F Stahl, Tanja Fauti, Nina Ullrich, et al.
Oncotarget|June 2, 2016
A key role of GARP in the immune suppressive tumor microenvironmentSusanne A Hahn, Annemarie Neuhoff, Jenny Landsberg, et al.
Advanced Healthcare Materials|May 31, 2017
Dendritic Mesoporous Silica Nanoparticles for pH-Stimuli-Responsive Drug Delivery of TNF-AlphaArne Kienzle, Sven Kurch, Janine Schlöder, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Allergy and Clinical Immunology|January 13, 2012
Allergen-induced IgE-dependent gut inflammation in a human PBMC-engrafted murine model of allergyBenno Weigmann, Nadja Schughart, Christian Wiebe, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2012
Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3+ regulatory T cellsMartin Vaeth, Ulrike Schliesser, Gerd Müller, et al.
The Journal of Biological Chemistry|June 7, 2006
Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responsesTobias Warger, Nobert Hilf, Gerd Rechtsteiner, et al.
Blood|May 15, 2009
Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cellsChristian Becker, Christian Taube, Tobias Bopp, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|May 4, 2013
Subclinical CNS inflammation as response to a myelin antigen in humanized miceMorad Zayoud, Khalifa El Malki, Katrin Frauenknecht, et al.
Blood|May 16, 2007
Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive functionJan Kubach, Petra Lutter, Tobias Bopp, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 4, 2015
FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosisFelix Luessi, Stefan Kraus, Bettina Trinschek, et al.
Plos One|September 25, 2009
miR-155 inhibition sensitizes CD4+ Th cells for TREG mediated suppressionHeiko F Stahl, Tanja Fauti, Nina Ullrich, et al.
Oncotarget|June 2, 2016
A key role of GARP in the immune suppressive tumor microenvironmentSusanne A Hahn, Annemarie Neuhoff, Jenny Landsberg, et al.
Advanced Healthcare Materials|May 31, 2017
Dendritic Mesoporous Silica Nanoparticles for pH-Stimuli-Responsive Drug Delivery of TNF-AlphaArne Kienzle, Sven Kurch, Janine Schlöder, et al.
Pageof 7